All Stories

  1. Knowledge, Attitudes, and Practice towards Rabies in Gharbia Governorate, Egypt: A Cross-Sectional Study
  2. Hemofiltration as an Alternative for IL-6 Inhibitors in COVID-19 Cytokines Storm Associated with Underlaying Bacterial Infections: A Review Article
  3. Triggers for Acceptance of COVID-19 Vaccination: A Community- Based Study
  4. Effect of Direct-Acting Antiviral Drugs on Erectile Functions among Hepatitis C Patients: A Prospective Interventional Study
  5. Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma
  6. Diagnosis of Inflammatory Bowel Disease by Abdominal Ultrasound and Color Doppler Techniques
  7. Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country
  8. The Correlation Between the Autotaxin Enzyme and Pruritus in Egyptian Patients Suffering from Chronic Liver Disease
  9. Insulin Growth Factor-1 as a Predictor for the Progression of Hepatic Disease in Chronic Hepatitis B Virus Infection
  10. Serum Vitamin D Levels in Chronic Hepatitis B Patients Before and During Treatment
  11. Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test for HBV Infection in Rheumatic Disease Patients Before Starting Immunosuppressive Therapies? A Cross-sectional Study
  12. A Comparison of Ultrasound and Fluoroscopy-guided Celiac Plexus Neurolysis in Patients with Pancreatic Cancer
  13. Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients
  14. Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer
  15. Chloroquine as chemoprophylaxis for COVID-19: Will this work?
  16. Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection
  17. The Effect of Stem Cell Transplantation Therapy for Post Viral Chronic Liver Cell Failure on Associated Type II Diabetes Mellitus: A Pilot Study
  18. Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
  19. Hepatitis C Virus: Efficacy of New DAAs Regimens
  20. Talin-1 Gene Expression as a Tumor Marker in Hepatocellular Carcinoma Patients: A Pilot Study
  21. The Role of Serum Procalcitonin Level as an Early Marker of Ascitic Fluid Infection in Post Hepatitic Cirrhotic Patients
  22. Randomised Study Comparing the use of Propofol Versus Dexmedetomidine as a Sedative Agent for Patients Presenting for Lower Gastrointestinal Endoscopy
  23. Protein C and Antithrombin III in liver cirrhosis staging
  24. Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy
  25. Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
  26. Evaluation of Fucosylated Haptoglobin as a Diagnostic Biomarker for Hepatocellular Carcinoma in Egypt
  27. Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis
  28. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation
  29. Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
  30. Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-analysis
  31. Diabetes association with liver diseases: an overview for clinicians
  32. Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone
  33. Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
  34. Sofosbuvir, pegylated interferon and ribavirin in treatment of an Egyptian cohort with hepatitis C virus infection in real life clinical practice.
  35. Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
  36. Predicting esophageal varices in cirrhotic hepatitis C virus patients using noninvasive measurement of insulin resistance variables
  37. Heat shock protein 47 as indispensible participant in liver fibrosis: Possible protective effect of lactoferrin
  38. Blood Ammonia Level Correlates with Severity of Cirrhotic Portal Hypertensive Gastropathy
  39. IL-1α correlates with severity of hepatitis C virus-related liver diseases
  40. Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration – a randomized controlled trial
  41. Efficacy and safety of sofosbuvir&ledipasvir for treatment of hepatitis C genotype 4 infection
  42. sofosbuvir plus daclatasvir with or without ribavirin in genotype 4 hepatitis C virus infection
  43. Pregabalin for analgesia in patients scheduled for RFA of focal lesions in the liver.
  44. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
  45. A novel scoring system for prediction of esophageal varices in critically ill patients
  46. Pilot study of orphenadrine as a novel treatment for muscle cramps in patients with liver cirrhosis
  47. scleroligation versus band ligation alone for eradication of gastroesophageal varices
  48. Sofosbuvir plus ribavirin with or without interferon for HCV
  49. NAFLD is associated with more severe stroke
  50. Role of Interleukin-12 B gene polymorphism in prediction of stage of liver disease
  51. Gastroprotective effects of montelukast and Nigella sativa oil
  52. Nitazoxanide based regimens in treating helicobacter infection
  53. . ANCA associated vasculitis with sofosbuvir
  54. Role of low-molecular-weight heparins in prevention of thromboembolic after TACE
  55. Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease
  56. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients.
  57. rifaximin versus norfloxacin for secondary prophylaxis of SBP
  58. Baclofen in treating muscle cramps in cirrhotic patients
  59. single-session TACE combined with microwave ablation or RFA in the treatment of HCC
  60. A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for H pylori
  61. Correlation of platelets count with endoscopic findings
  62. Study of Hepatic Steatosis Index in Patients with Chronic HCV Infection
  63. Non Invasive Diagnosis of Esophageal Varices: Can it Replace Screening Endoscopy?
  64. Is Spontaneous Bacterial Peritonitis still Responding to Third Generation Cephalosporins? : A Single Centre Experience
  65. Detection of Hypervirulent Klebsiella pneumoniae in Tanta University Hospital, Egypt
  66. Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis in Nile Delta and Its Impact on Clinical Outcome of these Patients
  67. Pigtail Catheter in Patients with Recurrent Hepatic Hydrothorax